The National Interest
> Also On This Region:
> Also On This Topic:

 

 

What is the DEA Smoking?
by Ted Galen Carpenter

12.17.2008

The Drug Enforcement Administration is in an optimistic mood. A new DEA report insists that the antidrug campaigns Washington has undertaken with Colombia and Mexico in recent years have dramatically slowed the flow of cocaine into the United States. The DEA's principal piece of evidence is that average street prices for the drug have soared over the past twenty-one months from $96.61 per gram to $182.73, which suggests “that we are placing significant stress on the drug delivery system.” There’s just one problem with the DEA’s proclamation of success. We’ve heard it all before. Many, many times before.

For example, in November 2005, the White House Office of National Drug Control Policy asserted that a 19 percent increase in cocaine prices since February indicated a growing retail shortage, thus validating Washington’s multibillion dollar Plan Colombia, designed to stanch the torrent of drugs coming from the Andean region of South America. “These numbers confirm that the levels of interdiction, the levels of eradication, have reduced the availability of cocaine in the United States,” White House drug czar John P. Walters boasted. “The policy is working.”

And what was the sky-high street price of cocaine that justified such optimism? $170 per gram. Adjusted for inflation, that price was actually higher than the latest price spike to just under $183. Yet clearly that earlier alleged supply-side victory in the drug war was short lived. According to the DEA’s own statistics in the December 2008 report, cocaine prices had declined to a mere $96 per gram by January 2007.

The reality is that street prices for illegal drugs act like the famous observation about prices in the stock market: they will vary. Over the past fifteen years, the retail price of cocaine has moved in a range between roughly $90 and $200 per gram. The latest spike is nothing abnormal, just as the plunge in prices from November 2005 to January 2007 was not unusual. Indeed, if one examines price trends over a longer period, any cause for optimism evaporates. During the early 1980s cocaine sometimes sold for more than $500 per gram. Obviously, that did not herald a lasting victory in the drug war.

Moreover, if the DEA has issued its 2008 report just three months earlier, there would have been even less evidence of supposed progress. For the previous five quarters, the street price had hovered around $120. The agency is simply grasping at straws to “prove” that the nearly four-decades-old effort to shut off the supply of illegal drugs is finally working.

Alas, facts are stubborn things. The DEA’s notion that Washington’s cooperation with Colombia has reduced the quantity of drugs coming out of South America is even disputed by another U.S. government agency. An October 2008 report to Congress by the Government Accountability Office found that coca cultivation and cocaine production in Colombia since the start of Plan Colombia in 2000 had actually increased.

Not only is the U.S. market for cocaine and other illicit drugs still healthy, the market elsewhere in the world is even more robust. The global drug trade is a vast, extremely lucrative enterprise, estimated at $320 billion a year. The United States is the largest single retail market, but the main areas of growth are in Central and Eastern Europe, the successor states of the former Soviet Union, and some portions of the Middle East and Latin America.

With such vast consumer demand, and with the black-market premium creating profit margins of 90 percent or more, there is little chance of shutting off the supply. The economic incentives to engage in drug trafficking are simply too powerful.

Government bureaucrats understandably go to great lengths to justify the mission of their agency. But the notion that the latest DEA report shows meaningful progress in the war against illegal drugs does not even pass the straight-face test. An effective strategy to deal with the drug issue cannot be based on wishful thinking and self-serving propaganda.

 

Ted Galen Carpenter, vice president for defense and foreign-policy studies at the Cato Institute, is the author of eight books on international affairs, including Smart Power: Toward a Prudent Foreign Policy for America (2008). He is also a contributing editor to The National Interest.

Other Articles by Ted Galen Carpenter:
01.19.10
Nouri al-Maliki is exhibiting worrying authoritarian tendencies.
12.23.09
Obama may sell weapons to Taiwan just to show the Chinese that he can’t be pushed around.
10.23.09
A nuclear-arms race in Asia is China’s nightmare. If we want Beijing’s help in stopping North Korea, we should retract our nuclear umbrella from South Korea and Japan.
09.21.09
If Moscow wants good relations with Washington, it needs to stop meddling in Latin America.
09.11.09
Mexican President Felipe Calderón's hard-line, military-driven drug war has backfired. It seems the government is intent on reducing aggression, but don't expect much to change. Violence is only going to get worse.
09.01.09
Nation building is a failed policy. So why are we trying it in Afghanistan?
07.09.09
Kim Jong Il wants attention, so let’s give it to him. Normalizing relations with North Korea will reveal the true reasons for its nuclear ambitions.
Subscribe Now

Copyright © 2006 The National Interest All rights reserved. | Legal Terms
P: (800) 344-7952, Outside the U.S.: (856) 380-4130 | backissues@nationalinterest.org
P.O. Box 9001, Maple Shade, NJ 08052-9662

The National Interest is published by The Nixon Center

The Nixon Center
1615 L Street, Suite 1250
Washington, DC 20036
www.nixoncenter.org